Not applicableStudy completedNCT00875407
What this trial is testing
Feasibility of 123I-IBZM Scintigraphy (a D2 Agonist) in Patients With Pheochromocytoma (PHEO) and/or Paraganglioma (PGL) : Study Pilot
Who this might be right for
Chromaffin-tissue Derived Tumors
Assistance Publique Hopitaux De Marseille 10